- Top Workplaces
- Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals, Inc. (“Cadence”) is a specialty biopharmaceutical company, focused on acquiring, in-licensing, developing & commercializing proprietary products utilized in the hospital setting. Cadence currently markets OFIRMEV® injection, a proprietary intravenous formulation of acetaminophen. OFIRMEV, a drug that Cadence acquired prior to its Phase III trials, was approved by the FDA in November 2010, launched in early 2011, & is now used in over 4,350 hospitals nationwide with an estimated 4.8-6.0 million hospitalized patients treated for pain &/or fever.